nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Dyspnoea—Mometasone—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Nafarelin—Malnutrition—Leflunomide—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Nafarelin—Rhinitis—Lisinopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Nafarelin—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Nafarelin—Decreased appetite—Mometasone—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Nafarelin—Dysgeusia—Leflunomide—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Nafarelin—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Nafarelin—Pulmonary embolism—Methotrexate—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Nafarelin—Shock—Captopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Nafarelin—Alopecia—Mycophenolic acid—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Nafarelin—Depression—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Nafarelin—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Nafarelin—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Nafarelin—Cystitis noninfective—Methotrexate—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Nafarelin—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Nafarelin—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Nafarelin—Anorexia—Captopril—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Nafarelin—Cystitis—Methotrexate—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Nafarelin—Asthenia—Pentoxifylline—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Nafarelin—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Nafarelin—Tension—Mycophenolic acid—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Nafarelin—Nervousness—Mycophenolic acid—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Nafarelin—Pruritus—Pentoxifylline—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Nafarelin—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Nafarelin—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Nafarelin—Increased appetite—Prednisone—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Nafarelin—Myalgia—Azathioprine—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Nafarelin—Arthralgia—Azathioprine—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Nafarelin—Vertigo—Leflunomide—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Nafarelin—Insomnia—Captopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Nafarelin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Nafarelin—Paraesthesia—Captopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Nafarelin—Palpitations—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Nafarelin—Dyspnoea—Captopril—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Nafarelin—Neoplasm—Methotrexate—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Nafarelin—Bladder pain—Methotrexate—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Nafarelin—Gynaecomastia—Methotrexate—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Nafarelin—Alopecia—Lisinopril—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Nafarelin—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Nafarelin—Mental disorder—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Nafarelin—Dizziness—Pentoxifylline—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Nafarelin—Decreased appetite—Captopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Nafarelin—Malnutrition—Lisinopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Nafarelin—Vertigo—Mycophenolic acid—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Nafarelin—Chest pain—Leflunomide—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Nafarelin—Arthralgia—Leflunomide—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Nafarelin—Myalgia—Leflunomide—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Nafarelin—Constipation—Captopril—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Nafarelin—Tension—Lisinopril—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Nafarelin—Palpitations—Mycophenolic acid—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Nafarelin—Dysgeusia—Lisinopril—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Nafarelin—Nervousness—Lisinopril—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Nafarelin—Affect lability—Prednisone—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Nafarelin—Vomiting—Pentoxifylline—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Nafarelin—Convulsion—Mycophenolic acid—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Nafarelin—Rash—Pentoxifylline—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Nafarelin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Nafarelin—Headache—Pentoxifylline—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Nafarelin—Myalgia—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Nafarelin—Chest pain—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Nafarelin—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Nafarelin—Asthenia—Mometasone—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Nafarelin—Mood swings—Prednisone—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Nafarelin—Pruritus—Mometasone—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Nafarelin—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Nafarelin—Oedema—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Nafarelin—Anorexia—Leflunomide—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Nafarelin—Dry skin—Prednisone—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Nafarelin—Nausea—Pentoxifylline—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Nafarelin—Vertigo—Lisinopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Nafarelin—Diarrhoea—Mometasone—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Nafarelin—Shock—Mycophenolic acid—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Nafarelin—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Nafarelin—Palpitations—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Nafarelin—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Nafarelin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Nafarelin—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Nafarelin—Muscular weakness—Prednisone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Nafarelin—Anorexia—Mycophenolic acid—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Nafarelin—Tension—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Nafarelin—Insomnia—Leflunomide—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Nafarelin—Abdominal distension—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Nafarelin—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Nafarelin—Paraesthesia—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Nafarelin—Myalgia—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Nafarelin—Chest pain—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Nafarelin—Arthralgia—Lisinopril—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Nafarelin—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Nafarelin—Dyspnoea—Leflunomide—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Nafarelin—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Nafarelin—Vomiting—Mometasone—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Nafarelin—Sweating increased—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Nafarelin—Rash—Mometasone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Nafarelin—Asthenia—Captopril—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Nafarelin—Dermatitis—Mometasone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Nafarelin—Decreased appetite—Leflunomide—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Nafarelin—Headache—Mometasone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Nafarelin—Insomnia—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Nafarelin—Oedema—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Nafarelin—Pruritus—Captopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Nafarelin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nafarelin—Constipation—Leflunomide—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nafarelin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Nafarelin—Shock—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Nafarelin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Nafarelin—Diarrhoea—Captopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Nafarelin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Nafarelin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Nafarelin—Mood swings—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Nafarelin—Nausea—Mometasone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Nafarelin—Anorexia—Lisinopril—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Nafarelin—Weight increased—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Nafarelin—Constipation—Mycophenolic acid—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Nafarelin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Nafarelin—Weight decreased—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Nafarelin—Dizziness—Captopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Nafarelin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Nafarelin—Depression—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Nafarelin—Urticaria—Leflunomide—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Nafarelin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Nafarelin—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Nafarelin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Nafarelin—Insomnia—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Nafarelin—Paraesthesia—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Nafarelin—Vomiting—Captopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Nafarelin—Dyspnoea—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Nafarelin—Rash—Captopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Nafarelin—Dermatitis—Captopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Nafarelin—Headache—Captopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Nafarelin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Nafarelin—Decreased appetite—Lisinopril—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Nafarelin—Shock—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Nafarelin—Constipation—Lisinopril—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Nafarelin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Nafarelin—Diarrhoea—Azathioprine—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Nafarelin—Nausea—Captopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Nafarelin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Nafarelin—Asthenia—Leflunomide—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Nafarelin—Pruritus—Leflunomide—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Nafarelin—Dysuria—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Nafarelin—Dizziness—Azathioprine—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Nafarelin—Asthenia—Mycophenolic acid—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Nafarelin—Diarrhoea—Leflunomide—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Nafarelin—Urticaria—Lisinopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Nafarelin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Nafarelin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Nafarelin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Nafarelin—Vomiting—Azathioprine—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Nafarelin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Nafarelin—Rash—Azathioprine—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Nafarelin—Dermatitis—Azathioprine—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Nafarelin—Depression—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Nafarelin—Headache—Azathioprine—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Nafarelin—Dizziness—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Nafarelin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000996	0.000996	CcSEcCtD
Nafarelin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Nafarelin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Nafarelin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00098	0.00098	CcSEcCtD
Nafarelin—Vomiting—Leflunomide—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Nafarelin—Alopecia—Prednisone—systemic scleroderma	0.000966	0.000966	CcSEcCtD
Nafarelin—Dizziness—Mycophenolic acid—systemic scleroderma	0.00096	0.00096	CcSEcCtD
Nafarelin—Epistaxis—Methotrexate—systemic scleroderma	0.00096	0.00096	CcSEcCtD
Nafarelin—Rash—Leflunomide—systemic scleroderma	0.000959	0.000959	CcSEcCtD
Nafarelin—Dermatitis—Leflunomide—systemic scleroderma	0.000959	0.000959	CcSEcCtD
Nafarelin—Mental disorder—Prednisone—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Nafarelin—Nausea—Azathioprine—systemic scleroderma	0.000957	0.000957	CcSEcCtD
Nafarelin—Headache—Leflunomide—systemic scleroderma	0.000953	0.000953	CcSEcCtD
Nafarelin—Malnutrition—Prednisone—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Nafarelin—Asthenia—Lisinopril—systemic scleroderma	0.000938	0.000938	CcSEcCtD
Nafarelin—Pruritus—Lisinopril—systemic scleroderma	0.000925	0.000925	CcSEcCtD
Nafarelin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000923	0.000923	CcSEcCtD
Nafarelin—Rash—Mycophenolic acid—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Nafarelin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Nafarelin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00091	0.00091	CcSEcCtD
Nafarelin—Headache—Mycophenolic acid—systemic scleroderma	0.000909	0.000909	CcSEcCtD
Nafarelin—Nausea—Leflunomide—systemic scleroderma	0.000904	0.000904	CcSEcCtD
Nafarelin—Diarrhoea—Lisinopril—systemic scleroderma	0.000895	0.000895	CcSEcCtD
Nafarelin—Dizziness—Lisinopril—systemic scleroderma	0.000865	0.000865	CcSEcCtD
Nafarelin—Nausea—Mycophenolic acid—systemic scleroderma	0.000862	0.000862	CcSEcCtD
Nafarelin—Vertigo—Prednisone—systemic scleroderma	0.000855	0.000855	CcSEcCtD
Nafarelin—Vomiting—Lisinopril—systemic scleroderma	0.000831	0.000831	CcSEcCtD
Nafarelin—Rash—Lisinopril—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Nafarelin—Convulsion—Prednisone—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Nafarelin—Dermatitis—Lisinopril—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Nafarelin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000822	0.000822	CcSEcCtD
Nafarelin—Headache—Lisinopril—systemic scleroderma	0.000819	0.000819	CcSEcCtD
Nafarelin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000811	0.000811	CcSEcCtD
Nafarelin—Arthralgia—Prednisone—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Nafarelin—Myalgia—Prednisone—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Nafarelin—Alopecia—Methotrexate—systemic scleroderma	0.000807	0.000807	CcSEcCtD
Nafarelin—Mental disorder—Methotrexate—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Nafarelin—Malnutrition—Methotrexate—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Nafarelin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Nafarelin—Dysgeusia—Methotrexate—systemic scleroderma	0.000779	0.000779	CcSEcCtD
Nafarelin—Nausea—Lisinopril—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Nafarelin—Oedema—Prednisone—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Nafarelin—Shock—Prednisone—systemic scleroderma	0.000764	0.000764	CcSEcCtD
Nafarelin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Nafarelin—Anorexia—Prednisone—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Nafarelin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000728	0.000728	CcSEcCtD
Nafarelin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Nafarelin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Nafarelin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000718	0.000718	CcSEcCtD
Nafarelin—Vertigo—Methotrexate—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Nafarelin—Insomnia—Prednisone—systemic scleroderma	0.000702	0.000702	CcSEcCtD
Nafarelin—Paraesthesia—Prednisone—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Nafarelin—Convulsion—Methotrexate—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Nafarelin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Nafarelin—Chest pain—Methotrexate—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Nafarelin—Arthralgia—Methotrexate—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Nafarelin—Myalgia—Methotrexate—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Nafarelin—Decreased appetite—Prednisone—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Nafarelin—Constipation—Prednisone—systemic scleroderma	0.000664	0.000664	CcSEcCtD
Nafarelin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Nafarelin—Anorexia—Methotrexate—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Nafarelin—Urticaria—Prednisone—systemic scleroderma	0.000617	0.000617	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000591	0.000591	CcSEcCtD
Nafarelin—Insomnia—Methotrexate—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Nafarelin—Paraesthesia—Methotrexate—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Nafarelin—Dyspnoea—Methotrexate—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Nafarelin—Decreased appetite—Methotrexate—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Nafarelin—Asthenia—Prednisone—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Nafarelin—Pruritus—Prednisone—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Nafarelin—Diarrhoea—Prednisone—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Nafarelin—Urticaria—Methotrexate—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Nafarelin—Dizziness—Prednisone—systemic scleroderma	0.000514	0.000514	CcSEcCtD
Nafarelin—Vomiting—Prednisone—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Nafarelin—Rash—Prednisone—systemic scleroderma	0.00049	0.00049	CcSEcCtD
Nafarelin—Dermatitis—Prednisone—systemic scleroderma	0.000489	0.000489	CcSEcCtD
Nafarelin—Headache—Prednisone—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Nafarelin—Asthenia—Methotrexate—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Nafarelin—Nausea—Prednisone—systemic scleroderma	0.000461	0.000461	CcSEcCtD
Nafarelin—Pruritus—Methotrexate—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Nafarelin—Diarrhoea—Methotrexate—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Nafarelin—Dizziness—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Nafarelin—Vomiting—Methotrexate—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Nafarelin—Rash—Methotrexate—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Nafarelin—Dermatitis—Methotrexate—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Nafarelin—Headache—Methotrexate—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Nafarelin—Nausea—Methotrexate—systemic scleroderma	0.000385	0.000385	CcSEcCtD
